Updated: June 13, 2026
About the program
Program type
Investment stage
Description
Led by physician-scientist Tom Cahill, they form companies from academic discoveries in gene editing and regenerative medicine, offering company-formation expertise, board experience, and a high formation-and-exit track record.
Location
Investment offer
Can lead rounds
No
Lead preference
Sometimes
Details
Avg Check: $50K - $10M ·
Funding requirements
We invest in life science ventures built on strong scientific principles.